Postdoctoral Position in Virology and Cancer

George

waitin' fer rabbits
Messages
851
Likes
80
Location
South Texas
Research goes on. (grins)


Postdoctoral Position in Virology and Cancer

Posted by: jana_clark

Postdoctoral positions are immediately available in the laboratory of Dr. Shan-Lu Liu in the Department of Molecular Microbiology and Immunology, University of Missouri, Columbia. The Liu lab is interested in retroviral pathogenesis, virus fusion and entry, as well as gene therapy using the HIV lentiviral vectors. While oncogenic sheep retroviruses associated with epithelial lung and nasal cancer in animals have been a major focus, the laboratory has recently initiated several new projects to study virus-host interactions for hepatitis C virus (HCV) that causes chronic and severe liver diseases, as well as the newly identified xenotropic MuLV-related virus (XMRV) that is associated with human prostate cancer and chronic fatigue syndrome. Highly motivated individuals with a track record of productivity in virology, cell biology or cancer biology are encouraged to apply. Candidates should hold a PhD degree in the field of virology, with experiences in vesicular trafficking and confocal microscopy being particularly sought. The laboratory is located in the recently established Bond Life Sciences Center at the University of Missouri, with a state-of-the-art research facility that fosters innovation, interactions and productivity.

Please forward a cover letter, resume, and the full contact information of three references to Dr. Shan-Lu Liu via email: liushan@health.missouri.edu or University of Missouri, Department of Molecular Microbiology and Immunology, M616 Medical Sciences Building, One Hospital Drive, Columbia, MO 65212.

The University of Missouri is an EOE/ADA employer. Women and minorities under-represented in biomedical research are encouraged to apply. For ADA accommodations, contact our ADA Coordinator at (573) 884-7278 (V/TTY).

This entry was posted on Thursday, July 8th, 2010 at 11:59 am and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.